Correlation Between DexCom and Renalytix
Can any of the company-specific risk be diversified away by investing in both DexCom and Renalytix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DexCom and Renalytix into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DexCom Inc and Renalytix AI, you can compare the effects of market volatilities on DexCom and Renalytix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DexCom with a short position of Renalytix. Check out your portfolio center. Please also check ongoing floating volatility patterns of DexCom and Renalytix.
Diversification Opportunities for DexCom and Renalytix
Pay attention - limited upside
The 3 months correlation between DexCom and Renalytix is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding DexCom Inc and Renalytix AI in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Renalytix AI and DexCom is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DexCom Inc are associated (or correlated) with Renalytix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Renalytix AI has no effect on the direction of DexCom i.e., DexCom and Renalytix go up and down completely randomly.
Pair Corralation between DexCom and Renalytix
If you would invest (100.00) in Renalytix AI on December 29, 2024 and sell it today you would earn a total of 100.00 from holding Renalytix AI or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
DexCom Inc vs. Renalytix AI
Performance |
Timeline |
DexCom Inc |
Renalytix AI |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
DexCom and Renalytix Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with DexCom and Renalytix
The main advantage of trading using opposite DexCom and Renalytix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DexCom position performs unexpectedly, Renalytix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Renalytix will offset losses from the drop in Renalytix's long position.DexCom vs. Tandem Diabetes Care | DexCom vs. Inspire Medical Systems | DexCom vs. Penumbra | DexCom vs. Insulet |
Renalytix vs. Streamline Health Solutions | Renalytix vs. HealthStream | Renalytix vs. National Research Corp | Renalytix vs. Forian Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |